Bridgeway Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $630K | Buy |
|
|||||
|
2025
Q1 | $442K | Buy |
|
|||||
|
2024
Q4 | $697K | Buy |
|
|||||
|
2024
Q3 | $229K | Buy |
|
|||||
|
2024
Q2 | $166K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.37M | Sell |
|
|||||
|
2021
Q1 | $5.4M | Sell |
|
|||||
|
2020
Q4 | $1.55M | Sell |
|
|||||
|
2020
Q3 | $705K | Hold |
|
|||||
|
2020
Q2 | $445K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $165K | Hold |
|
|||||
|
2019
Q3 | $95K | Hold |
|
|||||
|
2019
Q2 | $192K | Buy |
|